Abstract:
ISTN announced today the award of a $150,000 Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop a novel drug delivery system for ulcer treatment. The grant is part of NIH’s Bioengineering Nanotechnology Initiative, a special SBIR program for nanotechnologies useful to biomedicine. (PDF)